跳至主要内容
临床试验/ACTRN12620000591954
ACTRN12620000591954终止未知

A randomised trial on the effect of individualised versus non individualised theta burst transcranial magnetic stimulation on depression scores in patients with major depressive episodes.

Monash University0 个研究点目标入组 41 人开始时间: 2020年5月21日最近更新:
适应症

试验速览

阶段
未知
状态
终止
入组人数
41

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Diagnosis of major depressive disorder as a single or recurrent episode, in accordance with the Diagnostic and Statistical Manual of Mental Disorders 5th edition (DSM-V) with Mini-International Neuropsychiatric Interview-confirmed diagnosis.
  • 18-80 years of age.
  • Treatment resistant depression at Stage II of the Thase and Rush classification.
  • Montgomery–Asberg Depression Rating Scale (MADRS) score of >19 (moderate–severe depression).
  • No change or initiation of new antidepressant (or other psychoactive) therapy in the four weeks prior to screening.
  • Demonstrated capacity to give informed consent.

排除标准

  • Inability to provide informed consent
  • Medically unstable
  • Concomitant neurological disorder or a history of a seizure disorder.
  • Patients who are pregnant or breastfeeding.
  • Active suicidal intent
  • Any psychotic disorder or current active psychotic symptoms
  • Patients who have intracranial implants.

研究者

相似试验

Individualised Theta Burst Transcranial Magnetic... | 临床试验